{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:26:34Z","timestamp":1760549194050},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2012.9","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T19:58:57Z","timestamp":1332532737000},"page":"e62-e62","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study"],"prefix":"10.1038","volume":"2","author":[{"given":"A","family":"Andriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Caravita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Montanaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Villiv\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Siniscalchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Bongarzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"De Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Coppetelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Avvisati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Agrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Gaglioti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of GIMEMA: gruppo laziale MIELOMA MULTIPLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"BFbcj20129_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/bcr413","volume":"4","author":"JE Brown","year":"2002","unstructured":"Brown JE, Coleman RE . The role of bisphosphonates in breast cancer: the present and future role of bisphosphonates in the management of patients with breast cancer. Breast Cancer Res 2002; 4: 24\u201329.","journal-title":"Breast Cancer Res"},{"key":"BFbcj20129_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/annonc\/mdm442","volume":"19","author":"M Aapro","year":"2008","unstructured":"Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an expert panel. Ann Oncol 2008; 19: 420\u2013432.","journal-title":"Ann Oncol"},{"key":"BFbcj20129_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/rheumatology\/keg477","volume":"43","author":"J Donath","year":"2004","unstructured":"Donath J, Krasznai M, Fornet B, Gergely Jr P, Poor G . Effect of bisphosphonate in patient with Paget's disease of the skull. Rheumathology 2004; 43: 89\u201394.","journal-title":"Rheumathology"},{"key":"BFbcj20129_CR4","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"HG Bone","year":"2004","unstructured":"Bone HG, Hosking D, Devogelaer JD, Tucci JR, Emkey RD, Tonino RP . Ten Years\u2019 Experience with Alendronate for Osteoporosis in Postmenopausal Women. N Engl J Med 2004; 350: 1189\u20131199.","journal-title":"N Engl J Med"},{"key":"BFbcj20129_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00002018-199921050-00004","volume":"5","author":"N Zojer","year":"1999","unstructured":"Zojer N, Keck AV, Pecherstorfer M . Comparative Tolerability of Drug Therapies for Hypercalcaemia of Malignancy. Drug Saf 1999; 5: 389\u2013406.","journal-title":"Drug Saf"},{"key":"BFbcj20129_CR6","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/annonc\/mdn796","volume":"20","author":"E Terpos","year":"2009","unstructured":"Terpos E, Sezer O, Croucher PI, Garc\u00eda-Sanz R, Boccadoro M, San Miguel J et al. The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network. Ann Oncol 2009; 20: 1303\u20131317.","journal-title":"Ann Oncol"},{"key":"BFbcj20129_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1182\/asheducation-2006.1.356","volume":"515","author":"B Mehrotra","year":"2006","unstructured":"Mehrotra B, Ruggiero S . Bisphosphonate complications including osteonecrosis of the jaw. Hematology Am Soc Hematol Educ Program 2006; 515: 356\u2013360.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFbcj20129_CR8","first-page":"2961","volume":"12","author":"MJ Rogers","year":"1988","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88; 12: 2961\u20132978.","journal-title":"Cancer"},{"key":"BFbcj20129_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1254\/jphs.FMJ05004X2","volume":"100","author":"K Suzuki","year":"2006","unstructured":"Suzuki K, Takeyama S, Sakai Y, Yamada S, Shinoda H . Current Topics in Pharmacological Research on Bone Metabolism: Inhibitory Effects of Bisphosphonates on the Differentiation and Activity of Osteoclasts. J Pharmacol Sci 2006; 100: 189\u2013194.","journal-title":"J Pharmacol Sci"},{"key":"BFbcj20129_CR10","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1369\/jhc.5A6630.2005","volume":"53","author":"K Suzuki","year":"2005","unstructured":"Suzuki K, Takeyama S, Kikuchi T, Yamada S, Sodek J, Shinoda H . Osteoclast Responses to Lipopolysaccharide, Parathyroid Hormone and Bisphosphonates in Neonatal Murine Calvaria Analyzed by Laser Scanning Confocal Microscopy. J Histochem Cytochem 2005; 53: 1525\u20131537.","journal-title":"J Histochem Cytochem"},{"key":"BFbcj20129_CR11","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","volume":"137","author":"C Vitte","year":"1996","unstructured":"Vitte C, Fleisch H, Guenther HL . Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption. Endocrinology 1996; 137: 2324\u20132333.","journal-title":"Endocrinology"},{"key":"BFbcj20129_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S8756-3282(99)00197-0","volume":"25","author":"M Ito","year":"1999","unstructured":"Ito M, Amizuka N, Nakajima T, Ozawa H . Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone 1999; 25: 447\u2013452.","journal-title":"Bone"},{"key":"BFbcj20129_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1089\/jir.2005.25.144","volume":"25","author":"B Vincenzi","year":"2005","unstructured":"Vincenzi B, Santini D, Dicuonzo G, Battistoni F, Gavasci M, La Cesa A et al. Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients. J Interferon Cytokine Res 2005; 25: 144\u2013151.","journal-title":"J Interferon Cytokine Res"},{"key":"BFbcj20129_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.joms.2006.03.002","volume":"64","author":"T Delibasi","year":"2006","unstructured":"Delibasi T, Altundag K, Kanlioglu Y . Why osteonecrosis of the jaw after bisphosphonate treatment is more frequent in multiple myeloma than in solid tumors. J Oral Maxillofac Surg 2006; 64: 995\u2013996.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFbcj20129_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"LI Plotkin","year":"1999","unstructured":"Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T . Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calictonin. J Clin Invest 1999; 104: 1363\u20131374.","journal-title":"J Clin Invest"},{"key":"BFbcj20129_CR16","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"32","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM et al Novel antiangiogenic effects of the bisphosphonates compound zoledronic acid. J Pharmacol Exp Ther 2002; 32: 1055\u20131061.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFbcj20129_CR17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","volume":"14","author":"D Santini","year":"2003","unstructured":"Santini D, Vespasiani Gentilucci U, Vincenzi B, Picardi A, Vasaturo F, La Cesa A et al. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 2003; 14: 1468\u20131476.","journal-title":"Ann Oncol"},{"key":"BFbcj20129_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/sj.leu.2403693","volume":"19","author":"S Mariani","year":"2005","unstructured":"Mariani S, Muraro M, Pantaleoni F, Fiore F, Nuschak B, Peola S et al. Effector gamma delta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia 2005; 19: 664\u2013670.","journal-title":"Leukemia"},{"key":"BFbcj20129_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0278-2391(09)00013-5","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillo facial surg 2009; 67: 2\u201312.","journal-title":"J Oral Maxillo facial surg"},{"key":"BFbcj20129_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1034\/j.1600-0714.2000.291006.x","volume":"29","author":"MA Gonzalez- Moles","year":"2000","unstructured":"Gonzalez- Moles MA, Bagan-Sebastian JV . Aledronate-related oral mucosa ulcerations. J Oral Pathol Med 2000; 29: 514\u2013518.","journal-title":"J Oral Pathol Med"},{"key":"BFbcj20129_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s100670050116","volume":"18","author":"N Demerijan","year":"1999","unstructured":"Demerijan N, Bolla G, Spreux A . Severe oral ulcerations induced by alendronate. Clin Rheumatol 1999; 18: 349\u2013350.","journal-title":"Clin Rheumatol"},{"key":"BFbcj20129_CR22","volume-title":"Oral and Maxillofacial Pathology: A Rationale for Treatment","author":"RE Marx","year":"2002","unstructured":"Marx RE, Stern D eds). Oral and Maxillofacial Pathology: A Rationale for Treatment. Quintessence Publishing: Hanover Park, IL, 2002."},{"key":"BFbcj20129_CR23","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1080\/10428190802483778","volume":"49","author":"V Montefusco","year":"2008","unstructured":"Montefusco V, Gay F, Spina F, Miceli R, Maniezzo M, Teresa Ambrosini M et al. Antibiotic prophiylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leuk Lymphoma 2008; 49: 2156\u20132162.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj20129_CR24","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","volume":"23","author":"A Bamias","year":"2005","unstructured":"Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G et al. Osteoncrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005; 23: 8580\u20138587.","journal-title":"J Clin Oncol"},{"key":"BFbcj20129_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G et al. Decreased occurence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 2009; 20: 137\u2013145.","journal-title":"Ann Oncol"},{"key":"BFbcj20129_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/10428190600977690","volume":"48","author":"S Pozzi","year":"2007","unstructured":"Pozzi S, Marcheselli R, Sacchi S, Baldini L, Angrilli F, Pennese E et al. Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients. Gruppo Italiano Studio Linfomi. Leuk Lymphoma 2007; 48: 56\u201364.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj20129_CR27","first-page":"1","volume":"10","author":"The International Myeloma Working group","year":"2007","unstructured":"The International Myeloma Working group. International uniform response criteria for multiple myeloma. Leukemia 2007; 10: 1\u20137.","journal-title":"Leukemia"},{"key":"BFbcj20129_CR28","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00520-008-0484-3","volume":"16","author":"N La Verde","year":"2008","unstructured":"La Verde N, Bareggi C, Garassino M, Borgonovo K, Sburlati P, Pedretti D et al. Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution. Support Care Cancer 2008; 16: 1311\u20131315.","journal-title":"Support Care Cancer"},{"key":"BFbcj20129_CR29","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1200\/JCO.2008.16.9300","volume":"26","author":"A Badros","year":"2008","unstructured":"Badros A, Terpos E, Katodritou E, Goloubeva O, Kastritis E, Verrou E et al. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J Clin Oncol 2008; 26: 5904\u20135909.","journal-title":"J Clin Oncol"},{"key":"BFbcj20129_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1365-2141.2006.06230.x","volume":"134","author":"K Zervas","year":"2006","unstructured":"Zervas K, Verrou E, Teleioudis Z, Vahtsevanos K, Banti A, Mihou D et al. Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single centre experience in 303 patients. Br J Haematol 2006; 134: 620\u2013623.","journal-title":"Br J Haematol"},{"key":"BFbcj20129_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3324\/haematol.11096","volume":"92","author":"MT Petrucci","year":"2007","unstructured":"Petrucci MT, Gallucci C, Agrillo A, Mustazza MC, Fo\u00e0 R . Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients. Haematologica 2007; 92: 1289\u20131290.","journal-title":"Haematologica"},{"key":"BFbcj20129_CR32","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1080\/10428190802491706","volume":"49","author":"MA Gertz","year":"2008","unstructured":"Gertz MA, Koka S . The dilemma of jaw osteonecrosis in patients with multiple myeloma. Leuk Lymphoma 2008; 49: 2037\u20132039.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj20129_CR33","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.294.16.2035","volume":"294","author":"FJ Belda","year":"2005","unstructured":"Belda FJ, Aguilera L, Garc\u00eda de la Asunci\u00f3n J, Alberti J, Vicente R, Ferr\u00e1ndiz L et al. Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005; 294: 2035\u20132042.","journal-title":"JAMA"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj20129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj20129","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj20129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:39:47Z","timestamp":1672958387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj20129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3]]}},"alternative-id":["BFbcj20129"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2012.9","relation":{},"ISSN":["2044-5385"],"issn-type":[{"type":"electronic","value":"2044-5385"}],"subject":[],"published":{"date-parts":[[2012,3,23]]},"assertion":[{"value":"27 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}